Receptor tyrosine kinase inhibitors block multiple steps of influenza A virus replication

Journal of Virology

Volumn 85, Issue 6, 2011, Pages 2818-2827

  Kumar, Naveen ^a   Liang, Yuhong ^a,b   Parslow, Tristram G ^a   Liang, Yuying ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DI TERT BUTYL ALPHA CYANO 4 HYDROXYTHIOCINNAMAMIDE; A 9; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EXPORTIN 1; GERANYLTRANSFERASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE KINASE INHIBITOR; RIBAVIRIN; SHORT HAIRPIN RNA; TYRPHOSTIN A 9; TYRPHOSTIN AG 879; UNCLASSIFIED DRUG; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; INFLUENZA A; INFLUENZA VIRUS A; LIFE CYCLE; NUCLEAR EXPORT SIGNAL; PRIORITY JOURNAL; RNA SYNTHESIS; SIGNAL TRANSDUCTION; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TITRATION;

ANTIVIRAL AGENTS; CELL LINE; ENZYME INHIBITORS; HUMANS; INFLUENZA A VIRUS; RECEPTOR PROTEIN-TYROSINE KINASES; TYRPHOSTINS; VIRUS REPLICATION;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 79952408660     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01969-10     Document Type: Article

References (61)

1. Akarsu, H., et al. 2003. Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO J. 22:4646-4655. (Pubitemid 37162901)
2. Almond, J. W., and V. Felsenreich. 1982. Phosphorylation of the nucleoprotein of an avian influenza virus. J. Gen. Virol. 60:295-305.
3. Brass, A. L., et al. 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254.
4. Bukrinskaya, A. G., N. K. Vorkunova, G. V. Kornilayeva, R. A. Narmanbetova, and G. K. Vorkunova. 1982. Influenza virus uncoating in infected cells and effect of rimantadine. J. Gen. Virol. 60:49-59.
5. Chen, B. J., and R. A. Lamb. 2008. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology 372:221-232.
6. Chu, J. J., and P. L. Yang. 2007. c-Src protein kinase inhibitors block assembly and maturation of dengue virus. Proc. Natl. Acad. Sci. U. S. A. 104:3520-3525.
7. Cox, N. J., and K. Subbarao. 1999. Influenza. Lancet 354:1277-1282. (Pubitemid 29469365)
8. de Jong, M. D., et al. 2005. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353:2667-2672.
9. Ehrhardt, C., et al. 2006. Bivalent role of the phosphatidylinositol-3- kinase (PI3K) during influenza virus infection and host cell defence. Cell. Microbiol. 8:1336-1348.
10. Ehrhardt, C., et al. 2007. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J. Virol. 81:3058-3067. (Pubitemid 46456615)
11. Eierhoff, T., E. R. Hrincius, U. Rescher, S. Ludwig, and C. Ehrhardt. 2010. The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog. 6:e1001099.
12. Elton, D., et al. 2001. Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J. Virol. 75:408-419.
13. Gregoriades, A., T. Christie, and K. Markarian. 1984. The membrane (M1) protein of influenza virus occurs in two forms and is a phosphoprotein. J. Virol. 49:229-235.
14. Gregoriades, A., G. G. Guzman, and E. Paoletti. 1990. The phosphorylation of the integral membrane (M1) protein of influenza virus. Virus Res. 16:27-41.
15. Hale, B. G., D. Jackson, Y. H. Chen, R. A. Lamb, and R. E. Randall. 2006. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol- 3-kinase signaling. Proc. Natl. Acad. Sci. U. S. A. 103:14194-14199.
16. Hao, L., et al. 2008. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454:890-893.
17. Hay, A. J., A. J. Wolstenholme, J. J. Skehel, and M. H. Smith. 1985. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4:3021-3024.
18. Heldin, C. H. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80:213-223.
19. Hirsch, A. J., et al. 2005. The Src family kinase c-Yes is required for maturation of West Nile virus particles. J. Virol. 79:11943-11951. (Pubitemid 41279311)
20. Hui, E. K., and D. P. Nayak. 2002. Role of G protein and protein kinase signalling in influenza virus budding in MDCK cells. J. Gen. Virol. 83:3055-3066.
21. Hutten, S., and R. H. Kehlenbach. 2007. CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol. 17:193-201.
22. Karlas, A., et al. 2010. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463:818-822.
23. Kistner, O., K. Muller, and C. Scholtissek. 1989. Differential phosphorylation of the nucleoprotein of influenza A viruses. J. Gen. Virol. 70:2421-2431.
24. Konig, R., et al. 2010. Human host factors required for influenza virus replication. Nature 463:813-817.
25. Kumar, N., Z. T. Xin, Y. Liang, H. Ly, and Y. Liang. 2008. NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J. Virol. 82:9880-9889.
26. Le, Q. M., et al. 2005. Avian flu: isolation of drug-resistant H5N1 virus. Nature 437:1108. (Pubitemid 41509341)
27. Levitzki, A., and C. Gilon. 1991. Tyrphostins as molecular tools and potential antiproliferative drugs. Trends Pharmacol. Sci. 12:171-174.
28. Ma, K., A. M. Roy, and G. R. Whittaker. 2001. Nuclear export of influenza virus ribonucleoproteins: identification of an export intermediate at the nuclear periphery. Virology 282:215-220.
29. Martin, K., and A. Helenius. 1991. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67:117-130.
30. Momose, F., et al. 2001. Cellular splicing factor RAF-2p48/NPI-5/BAT1/ UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. J. Virol. 75:1899-1908. (Pubitemid 32110180)
31. Momose, F., et al. 2002. Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis. J. Biol. Chem. 277:45306-45314.
32. Naito, T., et al. 2007. An influenza virus replicon system in yeast identified Tat-SF1 as a stimulatory host factor for viral RNA synthesis. Proc. Natl. Acad. Sci. U. S. A. 104:18235-18240.
33. Nayak, D. P., E. K. Hui, and S. Barman. 2004. Assembly and budding of influenza virus. Virus Res. 106:147-165. (Pubitemid 39572961)
34. Neville, M., F. Stutz, L. Lee, L. I. Davis, and M. Rosbash. 1997. The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr. Biol. 7:767-775.
35. Ohmichi, M., et al. 1993. The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor. Biochemistry 32:4650-4658. (Pubitemid 23143256)
36. Osherov, N., A. Gazit, C. Gilon, and A. Levitzki. 1993. Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins. J. Biol. Chem. 268:11134-11142.
37. Palese, P., and R. W. Compans. 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J. Gen. Virol. 33:159-163.
38. Palese, P., and M. L. Shaw. 2007. Orthomyxoviridae: the viruses and their replication, p. 1647-1689. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
39. Palese, P., K. Tobita, M. Ueda, and R. W. Compans. 1974. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61:397-410.
40. Pawson, T. 1995. Protein modules and signalling networks. Nature 373:573-580.
41. Petri, T., and N. J. Dimmock. 1981. Phosphorylation of influenza virus nucleoprotein in vivo. J. Gen. Virol. 57:185-190.
42. Pleschka, S., et al. 2001. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell. Biol. 3:301-305.
43. Privalsky, M. L., and E. E. Penhoet. 1978. Influenza virus proteins: identity, synthesis, and modification analyzed by two-dimensional gel electrophoresis. Proc. Natl. Acad. Sci. U. S. A. 75:3625-3629.
44. Puthavathana, P., et al. 2005. Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. J. Gen. Virol. 86:423-433.
45. Regan, J. F., Y. Liang, and T. G. Parslow. 2006. Defective assembly of influenza A virus due to a mutation in the polymerase subunit PA. J. Virol. 80:252-261.
46. Richardson, J. C., and R. K. Akkina. 1991. NS2 protein of influenza virus is found in purified virus and phosphorylated in infected cells. Arch. Virol. 116:69-80.
47. Sanz-Ezquerro, J. J., et al. 1998. The PA influenza virus polymerase subunit is a phosphorylated protein. J. Gen. Virol. 79:471-478.
48. Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103:211-225.
49. Shapira, S. D., et al. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255-1267.
50. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569.
51. Stantchev, T. S., I. Markovic, W. G. Telford, K. A. Clouse, and C. C. Broder. 2007. The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. Virus Res. 123:178-189.
52. Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
53. Vela, E. M., G. C. Bowick, N. K. Herzog, and J. F. Aronson. 2008. Genistein treatment of cells inhibits arenavirus infection. Antiviral Res. 77:153-156.
54. Wang, X., E. R. Hinson, and P. Cresswell. 2007. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2:96-105. (Pubitemid 47209520)
55. Watanabe, K., et al. 2001. Inhibition of nuclear export of ribonucleoprotein complexes of influenza virus by leptomycin B. Virus Res. 77:31-42. (Pubitemid 32622808)
56. Watanabe, T., S. Watanabe, and Y. Kawaoka. 2010. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 7:427-439.
57. Whittaker, G., I. Kemler, and A. Helenius. 1995. Hyperphosphorylation of mutant influenza virus matrix protein, M1, causes its retention in the nucleus. J. Virol. 69:439-445.
58. Whittaker, G. R., and P. Digard. 2006. Entry and intracellular transport of influenza virus, p. 37-64. In Y. Kawaoka (ed.), Influenza virology - current topics. Caister Academic Press, Norwich, United Kingdom.
59. Winquist, A. G., K. Fukuda, C. B. Bridges, and N. Cox. 1999. Neuraminidase inhibitors for treatment of influenza A and B infections. MMWR Surveill. Summ. 48:1-9.
60. Yoon, S. O., et al. 2008. Ran-binding protein 3 phosphorylation links the Ras and PI3-kinase pathways to nucleocytoplasmic transport. Mol. Cell 29:362-375.
61. Yura, Y., H. Yoshida, and M. Sato. 1993. Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase. Arch. Virol. 132:451-461.